肿瘤

内源性凝血酶潜能作为卵巢癌静脉血栓栓塞的一个标志物

作者:F. Abu Saadeh等 来源:IGCS2012官网 日期:2012-11-02
导读

           内源性凝血酶潜能作为卵巢癌静脉血栓栓塞的一个标志物

  ENDOGENOUS THROMBIN POTENTIAL AS A MARKER FOR VENOUS THROMBOEMBOLISM IN OVARIAN CANCER

  F. Abu Saadeh1,2, L. Norris1, S. 

  内源性凝血酶潜能作为卵巢癌静脉血栓栓塞的一个标志物

  ENDOGENOUS THROMBIN POTENTIAL AS A MARKER FOR VENOUS THROMBOEMBOLISM IN OVARIAN CANCER

  F. Abu Saadeh1,2, L. Norris1, S. O'Toole1, R. Langhe1, N. Gleeson1,2

  1Department of Obstetrics & Gynaecology, Trinity College Dublin, 2Department of Gynaecology Oncology, St. James's Hospital, Dublin, Ireland

  Introduction: Gynaecological cancers are associated with an increased risk of venous thromboembolism (VTE). Endogenous Thrombin Potential (ETP) has shown potential as a predictive marker for VTE.

  Aim: To compare the procoagulant activity in plasma of patients with benign and malignant lesions of ovary using the (ETP) assay.

  Patients and methods: Blood samples were obtained from 89 patients with ovarian tumours ( 29 benign and 60 malignant). Thrombin generation in platelet-poor plasma was measured using the Calibrated Automated Thrombography. Lag time, peak thrombin production, area under the thrombin generation curve (ETP), time to peak (TTP) were determined.

  Results: Patients with ovarian clear cell carcinoma had higher peak thrombin production (p< 0.01) and greater ETP( p< 0.001)compared with benign ovarian tumours. In the neoadjuvant group peak thrombin production following thrombomodulin incubation was significantly higher than in the benign ovarian group (p< 0.01). In patients who developed VTE post surgery, higher levels of ETP and peak thrombin (p< 0.01) were found preoperatively compared with patients who did not develop VTE.

  Conclusions: Patients with clear cell cancer have increased procoagulant activity as measured by ETP assay. The increased procoagulant activity is likely to contribute to the higher incidence of VTE in these patients. This procoagulant activity may be caused by the increased TF expression by tumour tissue (which we have reported). Following chemotherapy patients have reduced sensitivity to thrombomodulin indicating a defect in the protein C inhibitory pathway. ETP may be a potential marker for VTE in Gynaecology oncology patients post surgery.

  更多精彩内容,请点击专题报道:http://zt.cmt.com.cn/zt/igcs2012/index.html

分享:

评论

我要跟帖
发表
回复 小鸭梨
发表

copyright©医学论坛网 版权所有,未经许可不得复制、转载或镜像

京ICP证120392号  京公网安备110105007198  京ICP备10215607号-1  互联网药品信息服务资格证书:(京)-非经营性-2017-0056
//站内统计 //百度统计 //谷歌统计 //站长统计
*我要反馈: 姓    名: 邮    箱: